Does ADALIMUMAB Cause Injection site hypersensitivity? 295 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 295 reports of Injection site hypersensitivity have been filed in association with ADALIMUMAB (YUSIMRY). This represents 0.1% of all adverse event reports for ADALIMUMAB.
295
Reports of Injection site hypersensitivity with ADALIMUMAB
0.1%
of all ADALIMUMAB reports
1
Deaths
44
Hospitalizations
How Dangerous Is Injection site hypersensitivity From ADALIMUMAB?
Of the 295 reports, 1 (0.3%) resulted in death, 44 (14.9%) required hospitalization.
Is Injection site hypersensitivity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ADALIMUMAB. However, 295 reports have been filed with the FAERS database.
What Other Side Effects Does ADALIMUMAB Cause?
Drug ineffective (71,926)
Pain (37,514)
Arthralgia (35,592)
Rheumatoid arthritis (29,817)
Fatigue (29,420)
Injection site pain (28,679)
Headache (19,891)
Nausea (19,299)
Rash (18,690)
Pain in extremity (18,319)
What Other Drugs Cause Injection site hypersensitivity?
ETANERCEPT (363)
TIRZEPATIDE (333)
DUPILUMAB (125)
TOCILIZUMAB (103)
METHOTREXATE (82)
DULAGLUTIDE (73)
IXEKIZUMAB (71)
OCTREOTIDE (67)
ANAKINRA (60)
GLATIRAMER (60)
Which ADALIMUMAB Alternatives Have Lower Injection site hypersensitivity Risk?
ADALIMUMAB vs ADALIMUMAB-AACF
ADALIMUMAB vs ADALIMUMAB-AATY
ADALIMUMAB vs ADALIMUMAB-ADAZ
ADALIMUMAB vs ADALIMUMAB-ADBM
ADALIMUMAB vs ADALIMUMAB-AFZB